VALNEVA (EPA:VLA) | Finanzwire

Basculer en Français

10742	Companies
230462	Keywords
158888	Articles
122433	Press releases

Home
Companies
VALNEVA

PRESS RELEASE

published on 08/20/2024 at 16:01, 1 year 10 months ago

Original-Research: Valneva SE (von First Berlin Equity Research GmbH): Buy
First Berlin Equity Research GmbH updates research on Valneva SE (ISIN: FR0004056851) with a BUY recommendation and EUR 8.60 price target. H1 product sales slightly below consensus but gross margin improving. Valneva maintains full-year guidance

First Berlin Equity Research Buy Recommendation Valneva SE EUR 8.60 Price Target H1 Product Sales
BRIEF

published on 08/13/2024 at 07:05, 1 year 11 months ago

Valneva Reports Half Year 2024 Financial Results and Provides Corporate Updates

Financial Results Cash Position Revenue Guidance Valneva Vaccine Development
PRESS RELEASE

published on 08/13/2024 at 07:00, 1 year 11 months ago

Valneva Reports Half Year 2024 Financial Results and Provides Corporate Updates
Valneva reports first-half 2024 financial results as total revenues reach €70.8 million with net profit of €34.0 million. Company confirms full-year guidance and updates strategic pipeline expansion

Revenues Financial Results Net Profit Valneva Strategic Pipeline
BRIEF

published on 08/06/2024 at 08:35, 1 year 11 months ago

Valneva Announces Share and Voting Right Changes as of July 31, 2024

Euronext Paris Voting Rights Shares Biopharmaceutical Valneva
PRESS RELEASE

published on 08/06/2024 at 08:30, 1 year 11 months ago

VALNEVA - Declaration of shares and voting rights: July 31, 2024
VALNEVA declared changes in shares and voting rights including sale, transfer, and granting of double voting rights on various dates

Voting Rights Shares Sale Transfer Valneva
BRIEF

published on 07/17/2024 at 22:05, 2 years ago

VALOR Phase 3 Trial: Valneva and Pfizer Finalize Primary Lyme Disease Vaccination

Clinical Test Valneva Pfizer VLA15 Lyme
PRESS RELEASE

published on 07/17/2024 at 22:00, 2 years ago

Phase 3 VALOR Lyme Disease Trial: Valneva and Pfizer Announce Primary Vaccination Series Completion
Phase 3 VALOR Lyme Disease Trial: Pfizer and Valneva announce completion of primary vaccination series with VLA15, progressing towards a Lyme disease vaccine

Valneva Lyme Disease Vaccine Pfizer VLA15 VALOR
BRIEF

published on 06/05/2024 at 07:05, 2 years 1 month ago

Valneva Announces Availability of Documentation for its Combined Shareholder Meeting and Provides Corporate Update

Executive Changes Corporate Update Valneva Shareholder Meeting
PRESS RELEASE

published on 06/05/2024 at 07:00, 2 years 1 month ago

Valneva Announces Availability of Documentation for its Combined Shareholder Meeting and Provides Corporate Update
Valneva announces availability of documentation for its Combined Shareholder Meeting on June 26, 2024, along with corporate update including change in General Counsel & Corporate Secretary. Kendra Wergin appointed as successor

Corporate Update Valneva General Counsel Shareholder Meeting Kendra Wergin
BRIEF

published on 05/21/2024 at 07:05, 2 years 1 month ago

Valneva appoints Dr Hanneke Schuitemaker as Scientific Director

Nomination R&D Valneva Vaccines Dr Hanneke Schuitemaker

Accesswire

Published on 07/17/2026 at 15:00, 20 hours 12 minutes ago

Four Nines Gold to Showcase Hayden Hill Opportunity to U.S. Investors at OTC Markets Virtual Investor Conference
Published on 07/17/2026 at 14:00, 21 hours 12 minutes ago

Redwood AI Announces Pricing of $3.5 Million Private Placement
Published on 07/17/2026 at 13:00, 22 hours 12 minutes ago

Blue Lagoon Surpasses $10 Million In Revenue As Dome Mountain Production Rises To 125 Tonnes Per Day
Published on 07/17/2026 at 01:00, 1 day 10 hours ago

RJK Explorations Ltd. Announces Closing of Private Placement for Gross Proceeds of $310,000
Published on 07/17/2026 at 00:00, 1 day 11 hours ago

LIR Life Sciences Signs Development Services Agreement with Oxygen Handel GmbH (OH) to Advance Regulatory and Preclinical Roadmap for Transdermal Obesity Pipeline

View all ACCESSWIRE

EQS Group

Published on 07/18/2026 at 08:00, 3 hours 12 minutes ago

Northern Data AG – Changes to the Supervisory Board and the Management Board
Published on 07/17/2026 at 20:35, 14 hours 37 minutes ago

Farizon Opens Global Spare Part Distribution Center to Strengthen International Aftersales Support
Published on 07/17/2026 at 18:55, 16 hours 17 minutes ago

CGTN: China vows to make AI a driver for shared prosperity amid widening AI divide
Published on 07/17/2026 at 18:45, 16 hours 27 minutes ago

NNS acquires shares in OCI
Published on 07/17/2026 at 18:32, 16 hours 40 minutes ago

Fuller, Smith & Turner PLC: Transaction in own shares

Les Echos

Published on 07/17/2026 at 18:31, 16 hours 41 minutes ago

Disclosure of transactions in own shares from July 13 to July 17, 2026
Published on 07/17/2026 at 18:00, 17 hours 12 minutes ago

Information regarding compliance with gender balance rules within the Board of Directors
Published on 07/17/2026 at 17:45, 17 hours 27 minutes ago

Imerys-07-2026-information-share-capital-and-voting-rights-as-of-30-June-2026
Published on 07/16/2026 at 18:08, 1 day 17 hours ago

Aéroports de Paris S.A - June and half-year 2026 traffic figures
Published on 07/16/2026 at 17:45, 1 day 17 hours ago

H1 2026 revenue: €6.1m (+14%)

View all LES ECHOS COMFI WIRE